Executive Officer at Imbria Pharmaceuticals

Where does Komal Joshi work?

Komal Joshi is Executive at Imbria Pharmaceuticals.

Where did Komal Joshi go to school?

Komal Joshi studied at Columbia Business School (Master of Business Administration, Executive Program (Sponsored by Credit Suisse)); Boston College (Bachelor of Science - BS, Finance with a concentration in International Studies); The Wharton School (The CFO: Becoming a Strategic Partner Program (Sponsored by Jounce Therapeutics)).

Komal Joshi

Executive at Imbria Pharmaceuticals

New York, New York, United States

Find your path to Komal

1,048 people in our graph share verified history with Komal — schools, employers, funds. One of them is your warm intro.

John TorreyunlockedKomal: together at Credit Suisse (2000–2002)

Komal: together at Axcella Health

×4Komal: together at Credit Suisse

Komal: together at Deutsche Bank

Executive at Imbria Pharmaceuticals

Intro paths

→

In turn, Komal can intro founders to Imbria Pharmaceuticals's investors below.

Imbria Pharmaceuticals's investors · 3

Catalio Capital ManagementNew York · since 2025 RA CapitalBoston · since 2025 SV Health InvestorsBoston · $1M – $20M checks · since 2025

Experience

Imbria PharmaceuticalsChief Financial Officercurrent2022 — presentNew York, NY & Boston, MA
LIB TherapeuticsChief Financial Officer2020 — 2022Cincinnati, Ohio, United States
Jounce Therapeutics, Inc.Head Strategic Finance2017 — 2020Cambridge, MA
Axcella HealthCorporate Financial Planning & Strategy2015 — 2017Cambridge, MA
Deutsche BankHealthcare Equity Capital Markets Vice President2013 — 2014New York, NY
BMO Capital MarketsHealthcare Investment Banking Vice President2010 — 2013New York, NY
Credit SuisseInvestment Banking and Equity Research2000 — 2009New York, NY & San Francisco, CA

Skills & more

Valuation20Financial Modeling15Due Diligence15Investment Banking19Equity Research6Strategic Analysis1Deal Execution2Client Relationship BuildingProject Coordination1Investment Advisory2Strategy6Capital Markets6

+8 more

FinanceMergers & AcquisitionsBankingAnalysisInvestmentsEquitiesCorporate FinanceGlobal Cross-Functional Team Leadership

Series 7, 63 and 79 accreditations (expired November 2017) — FINRA

From Komal's professional profile.

Frequently asked questions

Who is Komal Joshi?: Executive Officer at Imbria Pharmaceuticals
Where does Komal Joshi work?: Komal Joshi is Executive at Imbria Pharmaceuticals.
Where did Komal Joshi go to school?: Komal Joshi studied at Columbia Business School (Master of Business Administration, Executive Program (Sponsored by Credit Suisse)); Boston College (Bachelor of Science - BS, Finance with a concentration in International Studies); The Wharton School (The CFO: Becoming a Strategic Partner Program (Sponsored by Jounce Therapeutics)).

Same school

Also attended Columbia Business School1,170

Ryan PetersenFounder & CEO of Flexport Aryo TehranianManaging Director at Mayfair Equity Partners Yibo NianInvestment Director at Intel Capital Kesha CashFounder & General Partner at Impact America Fund Mahati SridharPartner, Rise of the Rest at Revolution Giuseppe IademarcoHead of Global Partnership at P101 Ventures

+ 1,164 more

Also attended Boston College451

Pat GradyPartner at Sequoia Capital David FialkowVenture capitalist and Academy Award-winning documentary filmmaker who co-founded General Catalyst Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Bijan SabetPersonal journal Steve MurrayAdvisor, Revolution Growth at Revolution Natalie SchmitkeManaging Director Capital Networks at Burda Principal Investments

+ 445 more

Also attended The Wharton School2,000

Fred WilsonCo-founder & Partner at Union Square Ventures Sarah GuoFounder & General Partner of Conviction Josh KopelmanFounder and Partner at First Round Capital Aydin SenkutFounder & Managing Partner at Felicis Kunal BahlCo-founder of Snapdeal; co-founder of Titan Capital Jack AbrahamFounder, CEO & Managing Partner of Atomic

+ 1,994 more

Also attended The University of Hong Kong173

Roni HiranandInvestor at GV (Google Ventures)Anshul RuparellVenture Partner at FJ Labs Johan AkessonAssociate at Marlin Equity Partners Fan WenPrincipal & Director of AI at Fin Capital Jenny XiaoPartner at Leonis Capital Géraldine FilletSenior Associate at Educapital

+ 167 more

Shared employers

Also worked at Imbria Pharmaceuticals6

Ken HorneManaging Partner at AN Venture Partners Charles DunnPrincipal at SV Health Investors Laura TadvalkarManaging Director, Venture at RA Capital Alvin ShihCEO at Imbria Albert M. KimChief Medical Officer at Imbria Hugo FryChief Executive Officer at Topas Therapeutics

Also worked at Jounce Therapeutics, Inc.7

Jigar RaythathaInvestor at Third Rock Ventures Jason FullerPartner at Deerfield Management Company Dmitri WiederschainExecutive Officer at Crossbow Therapeutics Monica GostissaChief Science Officer at Matrisome Bio Tatiana NovobrantsevaChief Scientific Officer at NextPoint Therapeutics Igor FeldmanFounder at Verseau Therapeutics

+ 1 more

Also worked at Axcella Health7

Noubar AfeyanInvestor at Flagship Pioneering Shreeram AradhyeInvestor at Novartis Venture Fund Raffi FreemanInvestor at Clean Energy Venture Phillip SamayoaPrincipal at Atlas Venture Geoffrey von MaltzahnGeneral Partner at Flagship Pioneering William HinshawExecutive Officer, Director at FORE US Bio

+ 1 more

Also worked at Deutsche Bank976

Bill GurleyGeneral Partner Emeritus at Benchmark Vlad YatsenkoCo-founder & CTO of Revolut Funmi GarrickFinance and Operations at Impact America Fund Giuseppe IademarcoHead of Global Partnership at P101 Ventures Jeppe ZinkPartner at Northzone Dan MoreheadFounder & CEO at Pantera Capital

+ 970 more